Ifosfamide;Mesna Solution For Injection 50-100Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ifosfamide;Mesna: Solution for injection (50-100mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

IFOSFAMIDE (eye FOS fa mide) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat testicular cancer.

In-Depth Information

Ifosfamide 3g/60ml and Mesna 1g/10ml Kit

NDC: 007034100
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Testicular Cancer

Sometimes used for but not FDA approved for the following conditions:
Thymoma, Non-Hodgkin's Lymphoma (NHL), Thymic Carcinoma, Penile Cancer, Stem Cell Transplant Preparation, Desmoid Tumor, Soft-tissue Sarcoma, Rhabdomyosarcoma, Ewing's Sarcoma, Osteogenic Sarcoma

Storage Information
Refrigerate (between 36 and 46 degrees F)
Ifosfamide 3g/60ml and Mesna 1g/10ml Kit

Reported Side Effects for Ifosfamide 3g/60ml and Mesna 1g/10ml Kit

Confusion Incidence:
<15.4%*
Severity: MODERATE
Onset: EARLY
Lightheadedness Incidence:
<15.4%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<1.8%*
Severity: MODERATE
Onset: DELAYED
Hallucinations Incidence:
<15.4%*
Severity: MODERATE
Onset: EARLY
Yellow Skin Incidence:
<1.8%*
Severity: MODERATE
Onset: DELAYED
Psychosis Incidence:
<15.4%*
Severity: MODERATE
Onset: EARLY
Convulsions Incidence:
<15.4%*
Severity: SEVERE
Onset: DELAYED
Acute Cerebellar Syndrome Incidence:
<15.4%*
Severity: SEVERE
Onset: EARLY
Unable To Speak Incidence:
<15.4%*
Severity: MODERATE
Onset: DELAYED
Weakness Incidence:
<15.4%*
Severity: MILD
Onset: DELAYED
Incoordination Incidence:
<15.4%*
Severity: MODERATE
Onset: DELAYED
Restlessness Incidence:
<15.4%*
Severity: MILD
Onset: EARLY
Decreased Memory Incidence:
<15.4%*
Severity: MODERATE
Onset: DELAYED
Decreased Thinking Incidence:
<15.4%*
Severity: MODERATE
Onset: EARLY
Tiredness Incidence:
<15.4%*
Severity: MILD
Onset: EARLY
Low Lymphocytes Incidence:
<43.5%*
Severity: MODERATE
Onset: DELAYED
Rash With Pustules Incidence:
<0.1%*
Severity: MILD
Onset: EARLY
Rapid Muscle Twitches Incidence:
<15.4%*
Severity: MODERATE
Onset: DELAYED
Pancytopenia Incidence:
<43.5%*
Severity: SEVERE
Onset: DELAYED
Painful Urination Incidence:
<44.1%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
<15.4%*
Severity: MILD
Onset: EARLY
Heart Failure Incidence:
<0.5%*
Severity: SEVERE
Onset: DELAYED
Painful Bloody Urine Incidence:
<44.1%*
Severity: SEVERE
Onset: DELAYED
High Bilirubin Level Incidence:
<1.8%*
Severity: MODERATE
Onset: DELAYED
Distressed Incidence:
<15.4%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
<15.4%*
Severity: MILD
Onset: DELAYED
Coma Incidence:
<15.4%*
Severity: SEVERE
Onset: EARLY
Depression Incidence:
<15.4%*
Severity: MODERATE
Onset: DELAYED
Drowsiness Incidence:
<15.4%*
Severity: MILD
Onset: EARLY
Low Platelet Count Incidence:
<4.8%*
Severity: SEVERE
Onset: DELAYED
Shaking Incidence:
<15.4%*
Severity: MILD
Onset: EARLY
Uncontrolled Urination Incidence:
<15.4%*
Severity: MODERATE
Onset: EARLY
Brain Dysfunction Incidence:
<15.4%*
Severity: MODERATE
Onset: DELAYED
Electrolyte Imbalance Incidence:
<31.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
<43.5%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
0.3%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
0.3%*
Severity: MODERATE
Onset: RAPID
Mouth Ulcers Incidence:
0.3%*
Severity: MODERATE
Onset: DELAYED
Nerve Pain Incidence:
0.4%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
0.7%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
1.1%*
Severity: MILD
Onset: DELAYED
Irritated Blood Vessels Incidence:
2.8%*
Severity: MODERATE
Onset: RAPID
Blood In The Urine Incidence:
5.2-44.1%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
9.9%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
37.9%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
42.5-43.5%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
48.6%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
48.6%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
89.6%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Ifosfamide 3g/60ml and Mesna 1g/10ml Kit

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and Ifosfamide 3g/60ml and Mesna 1g/10ml Kit(Ifosfamide)
Grapefruit juice and Ifosfamide(Ifosfamide)
Do not take grapefruit juice with this medicine without approval from your prescriber. Grapefruit juice may reduce the effectiveness of Ifosfamide.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ifosfamide;Mesna

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5